根治性前列腺切除术前减重的II期前瞻性随机试验
本II期前瞻性随机试验将超重和肥胖的前列腺癌根治性前列腺切除术患者随机分配至5-8周减重项目(结构化限能量膳食1200-1500 Kcal/天+体力活动)或对照组。干预组体重下降和总脂肪量减少显著多于对照组,甘油三酯和胰岛素水平显著降低,但两组间凋亡指数和增殖指数无显著差异。
要点
- 干预组体重下降-3.7±0.5 kg vs 对照组-1.6±0.5 kg(p=0.007),总脂肪量干预组-2.1±0.4 vs 对照组0.1±0.3(p=0.015)。
- 两组间前列腺切除组织恶性上皮凋亡指数和增殖指数(Ki67)无显著差异。
- 干预组甘油三酯和胰岛素水平较对照组显著降低。
核心结论
- 根治性前列腺切除术前短期减重项目使干预组体重下降和体脂减少显著多于对照组,并伴随循环甘油三酯和胰岛素显著降低。
- 但恶性上皮凋亡或增殖未见显著变化。
- 未来研究应考虑更长疗程或更强化的减重干预。
研究设计与样本
- II期前瞻性随机试验,纳入计划行根治性前列腺切除术的超重和肥胖男性。
- 随机分配至5-8周减重项目(结构化限能量膳食1200-1500 Kcal/天+体力活动)或对照组。
- 共23例随机至减重干预组,21例至对照组。
- 主要终点为根治性前列腺切除标本恶性上皮凋亡指数。
主要发现
- 干预组体重下降-3.7±0.5 kg vs 对照组-1.6±0.5 kg(p=0.007),干预组下降更多。
- 干预组总脂肪量-2.1±0.4 vs 对照组0.1±0.3(p=0.015),干预组显著减少。
- 两组间凋亡指数或增殖指数无显著差异。
- 干预组较对照组甘油三酯和胰岛素水平显著降低。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is associated with poorly differentiated and advanced prostate cancer and increased mortality. In preclinical models, caloric restriction delays prostate cancer progression and prolongs survival. We sought to determine if weight loss (WL) in men with prostate cancer prior to radical prostatectomy affects tumor apoptosis and proliferation, and if WL effects other metabolic biomarkers. METHODS: In this Phase II prospective trial, overweight and obese men scheduled for radical prostatectomy were randomized to a 5-8 week WL program consisting of standard structured energy-restricted meal plans (1200-1500 Kcal/day) and physical activity or to a control group. The primary endpoint was apoptotic index in the radical prostatectomy malignant epithelium. Secondary endpoints were proliferation (Ki67) in the radical prostatectomy tissue, body weight, body mass index (BMI), waist to hip ratio, body composition, and serum PSA, insulin, triglyceride, cholesterol, testosterone, estradiol, leptin, adiponectin, interleukin 6, interleukin 8, insulin-like growth factor 1, and IGF binding protein 1. RESULTS: In total 23 patients were randomized to the WL intervention and 21 patients to the control group. Subjects in the intervention group had significantly more weight loss (WL:-3.7 ± 0.5 kg; Control:-1.6 ± 0.5 kg; p = 0.007) than the control group and total fat mass was significantly reduced (WL:-2.1 ± 0.4; Control: 0.1 ± 0.3; p = 0.015). There was no significant difference in apoptotic or proliferation index between the groups. Among the other biomarkers, triglyceride, and insulin levels were significantly decreased in the WL compared with the control group. CONCLUSIONS: In summary, this short-term WL program prior to radical prostatectomy resulted in significantly more WL in the intervention vs. the control group and was accompanied by significant reductions in body fat mass, circulating triglycerides, and insulin. However, no significant changes were observed in malignant epithelium apoptosis or proliferation. Future studies should consider a longer term or more intensive weight loss intervention.
引用
- Henning SM, Galet C, Gollapudi K, et al. Phase II prospective randomized trial of weight loss prior to radical prostatectomy. Prostate Cancer Prostatic Dis. 2017. PMID: 29203893. doi:10.1038/s41391-017-0001-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。